Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Investigating the proteasome stress response as a potential novel therapeutic target in myeloma

Giada Bianchi, MD, Brigham and Women’s Hospital & Dana-Farber Cancer Institute, Boston, MA, discusses ongoing research in which a mammalian reporter cell line was developed to analyze the proteasome stress response (PSR) in multiple myeloma, and explains how this research may be used to identify novel therapeutic strategies in this disease. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.